Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

FDG-PET/CT In the Evaluation of Persistent Febrile Neutropenia in Cancer Patients

NCT00707213 is registered in ClinicalTrials.gov with University of Utah as lead sponsor.

NCT NCT00707213
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00707213 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
FDG-PET/CT In the Evaluation of Persistent Febrile Neutropenia in Cancer Patients
Lead sponsor
University of Utah
Phase
Phase 1
Overall status
Terminated
Start date
August 21, 2007
Completion date
August 11, 2010
Enrollment
19 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer